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(57) ABSTRACT 
A diagnosis method for respiratory disease based on the 
separation of the expired airway phase in an exhaled breath 
from the alveolar phase, and a device to accomplish the 
method. The device includes a cartridge assembly and a 
disposable condensing chamber carried in a substantially 
enclosed housing. The cartridge assembly includes a dis-
posable cartridge and a reusable control system that moni-
tors a characteristic of gas passing through the cartridge to 
determine when to divert the exhaled breath to an exhaust 
outlet and when to divert the exhaled breath to the condens-
ing chamber. The characteristic is selected as being repre-
sentative of the transition from the expired airway phase to 
the alveolar phase. Also included are a refrigeration system, 
an auxiliary monitoring system for determining when a 
sufficient volume of gas has been produced, and a built-in 
analyzer. 
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DEVICE AND METHOD FOR COLLECTION OF 
EXHALED ALVEOLAR BREATH CONDENSATE 
CROSS-REFERENCE TO RELATED 
APPLICATION 
[0001] This application is entitled to the benefit of, and 
claims priority to, provisional U.S. patent application Ser. 
No. 60/447,581 filed Feb. 14, 2003 and entitled "DEVICE 
AND METHOD FOR COLLECTION OF EXHALED 
ALVEOLAR BREATH CONDENSATE," the entirety of 
which is incorporated herein by reference. 
BACKGROUND OF THE PRESENT 
INVENTION 
[0002] 1. Field of the Present Invention 
[0003] The present invention relates generally to breath 
condensate collection, and more particularly, to full-featured 
breath condensate collection apparatuses capable of sepa-
rating the expired airway phase of mammalian exhalation 
from the alveolar phase. 
[0004] 2. Background 
[0005] As is well known, exhaled breath condensate con-
tains water-soluble and water insoluble molecules, including 
dissolved gases, organic solutes, ions and proteins. Analysis 
of the molecular content of breath condensate can provide a 
method to diagnose and prognose certain diseases. (S. A 
Kharitonov and P. J. Barnes, Exhaled markers of pulmonary 
disease, Am J Respir Crit Care Med 163:1693-1722, 2001.) 
However, the measurement of substances in exhaled con-
densate as a method to determine the presence of patho-
physiologic processes in the lung alveoli is degraded by 
contamination by substances arising from the mouth, nose, 
throat and the tracheobronchial tree. Using two dimensional 
gel electrophoresis, Griese and colleagues demonstrated 
distinctly different proteins in breath condensate collected 
from oral breathing, compared with nasal breathing (M. 
Griese, Proteomics 2:690-696, 2002.) This contamination 
can cause false positive testing. 
[0006] It is our hypothesis that a gating mechanism can be 
triggered from the measurement of the partial pressure of 
carbon dioxide in exhaled breath to open and close during 
the exhalation cycle in a manner to separate out the con-
taminant breath volume, generated during the expired air-
way phase of the exhalation cycle, from the alveolar volume 
generated during the alveolar phase of the cycle. The ability 
to selectively collect alveolar breath condensate rapidly and 
easily with a point-of-care device would improve the clinical 
utility of breath-based diagnosis for this purpose, particu-
larly in the emergency department or clinic setting. The 
device described is designed to allow a patient to breath into 
a handheld disposable chamber to facilitate the collection of 
breath water vapor which can then be analyzed for bio-
chemicals to detect the presence of specific diseases, includ-
ing bacterial, chlamydial, mycoplasma, or fungal pulmonary 
infection, pulmonary embolism, pulmonary ischemia, sys-
temic gram negative sepsis, fat embolism from sickle cell 
disease or after surgical fixation of fractures, carcinoma of 
the lung, asthmatic inflammation, and chronic obstructive 
pulmonary disease. 
Experimental History and Observations Leading to 
Conception of Invention. 
[0007] An experimental pulmonary vascular occlusion 
(PYO), induced by venous infusion of polystyrene micro-
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spheres in rats, has been used to determine three major 
findings related to the device of the present invention. Using 
anesthetized, tracheostomized mechanically ventilated rats, 
exhaled-breath condensate was collected in a pilot version of 
the present invention. The condensing chamber consisted of 
a sterile pipette within dry ice. As compared with control 
rats, increased concentrations of proteins, eicosinoid deriva-
tives and peptides associated with fibrinolysis were found in 
the condensate of rats with PYO. (Nakos, Arn J Resp Crit 
Care Med 1998, 158:1504.) The magnitude of the concen-
tration of these vasoconstrictive agents correlated with the 
severity of hypoxemia and pulmonary hypertension in the 
subject rats. 
[0008] A variety of methods and apparatuses have been 
proposed for use in breath analysis, but none accomplish the 
needs and benefits of the present invention. Several of these, 
including U.S. Pat. Nos. 6,033,368 and 6,419,634 to Gaston 
et al., U.S. Pat. No. 6,585,661 to Hunt et al., U.S. Publication 
No. 2003/0208132 Al to Baddour, Eur. Patent No. 0,759, 
169 Bl to Winsel et al., and PCT Patent App. No. 02/082977 
to Vaughan et al., disclose breath condensate collection 
devices, but each has significant shortcomings. First, no 
known apparatus includes the use of a monitoring system in 
a breath condensate collection device as a mechanism to 
trigger a valve open and shut during the exhalation cycle for 
the purpose of collecting only one type of condensate-i.e., 
alveolar condensate or expired airway condensate. The 
former type of condensate is especially important in the use 
of a breath collection device to diagnose lower tract pulmo-
nary infection, as it is necessary to eliminate contamination 
of the breath sample from the nasopharyngeal flora. Simi-
larly, the latter type of condensate is especially important in 
diagnosing upper tract infection. 
[0009] Other devices or methods are known for separating 
the expired airway phase from the alveolar phase for such 
purposes as the detection of alcohol levels in a person's 
breath. For example, U.S. Pat. No. 3,613,665 to Gorsuch, 
U.S. Pat. No. 3,830,630 to Kiefer, U.S. Pat. No. 4,248,245 
to Kempin, U.S. Pat. No. 5,327,901 to Delente, U.S. Pat. No. 
5,376,555 to Forrester disclose methods and apparatuses for 
achieving such separation. Some, but not all, of these 
devices and methods use active mechanisms for providing 
such separation, while others use passive means. Unfortu-
nately, all known devices and methods suffer drawbacks. For 
example, the Gorsuch device measures temperature with a 
heated thermistor and triggers a valve when the temperature 
differential indicates that the alveolar phase has been 
reached, while the Kempin device measures temperature 
differentials to determine when to divert exhaled breath into 
a measuring chamber. Temperature-based valve triggers 
may not be as reliable as desired. Neither the Kiefer device 
nor the methodology disclosed by Forrester is used to 
physically separate the alveolar phase breath from expired 
airway phase breath. Instead, the filament used in Kiefer is 
used merely to activate an alcohol-measuring section, while 
the Forrester methodology uses automated analysis of infra-
red profiles of the exhaled breath to identify the different 
phases thereof. Finally, the Delente device is passive, relying 
on a simple technique to retain in a collection chamber only 
the last portion of an exhaled breath, which is assumed to be 
alveolar phase rather than expired airway phase because it 
comes from the end of the exhaled breath. None of these 
devices or methods are thus suitable for use in breath 
condensate collection. 
US 2004/0162500 Al 
[0010] Moreover, none of the known devices or methods 
for separating the expired airway phase from the alveolar 
phase have been applied to breath condensate collection 
devices. In fact, some of the devices, such as the Kempin 
device, takes steps or include features specifically to avoid 
condensation because it interferes with the measurement of 
the gases themselves. Finally, although the Forrester meth-
odology uses infrared analysis of exhaled breath, none of the 
devices or methods use spectrometry methods to determine 
when the alveolar phase of an exhaled breath has been 
reached and to trigger a valve creating physical separation of 
the alveolar phase from the expired airway phase. 
[0011] A need exists for a specific condensation chamber 
designed to allow delivery of a sample of condensate to an 
analysis system that is separate from the machine in order to 
allow point-of-care immunoassay for certain antigens. In 
particular, a need exists for an immunoassay in the form of 
a small plastic cartridge, similar to a conventional home 
pregnancy test kit except that the antibodies in the matrix are 
directed against antigens that will help diagnose pulmonary 
embolism and pulmonary infection. Antibodies that will 
preferably be tested may include, but are not limited to, 
fibrinopeptide A, d-dimer, thromboxane (and its metabo-
lites), leukotrienes, chemokines, interleukins, and bacterial, 
chlamydial, viral and mycoplasma antigens. Although the 
general intent of methodologies such as those disclosed in 
the Baddour and Vaughn patents may be somewhat similar 
to some of the purposes of the present invention, they fail to 
provide an apparatus for collecting condensate and then 
injecting approximately 50-500 µL of condensate from a tip 
into the immunoassay kit. In addition, a need exists for a 
device from which the condensate sample may be delivered 
to an arterial blood gas machine for analysis of pH, pC02 , 
p02 , lactate, urea, glucose and electrolytes. 
[0012] The Baddour device is designed to collect exhaled 
breath condensate from patients with asthma. The Baddour 
device does not describe a plunger that extrudes the sample, 
but describes a "duckbill" valve that appears to be an 
internal chamber for sample collection. This must be 
removed and requires additional steps before the sample can 
be analyzed. Baddour fails to disclose a tip which can be 
used to dispense the condensate onto the immunoassay filter, 
and fails to disclose a system of snaps to lock the handle of 
the plunger in its "closed" position. All of these features are 
very useful in facilitating simple breath condensate collec-
tion and analysis. Neither the specific objective of injecting 
the sample onto a port of an immunoassay, nor the objective 
of being able to use the condenser as a delivery unit to 
perform point-of-care pH, gas tension, lactate and urea 
measurements can be done with either the Baddour or 
Vaughn device. 
[0013] Although the Vaughn device appears to propose the 
use of an endothermic reaction to cool a condensing cham-
ber, it does not disclose a means of packaging the reaction 
to make it easy to use at the patient's bedside. The Vaughn 
device also requires a complicated methodology for express-
ing collected condensate from a side port of the condensing 
chamber. A need exists for a simpler methodology. 
[0014] No prior art device uses a flow transducer to 
indicate when an adequate volume of breath has been 
collected, or provides visual or aural feedback as to the rate 
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and completion percentage. A device having such features 
would be much more convenient to use than prior art 
devices. 
[0015] Further, no prior art device uses a high efficiency, 
miniature refrigeration unit, disposed within the breath col-
lection device itself, to cool the breath condenser. Such a 
system would allow a new condensing chamber to be cooled 
rapidly without storing the chamber beforehand in a freezer 
and without resorting to means such as an endothermic 
reaction to provide a cooling effect. 
[0016] A need exists for a full-featured breath condensate 
collection apparatus for separating alveolar phase exhaled 
breath from expired airway phase exhaled breath, having 
improved cooling features, a housing that substantially 
encloses the various components in order to protect them, to 
protect the user from uncomfortable heat or cold produced 
thereby, to avoid contamination to or from the components, 
to provide greater convenience of use to the user, and to 
provide built-in analysis of the condensate collected therein. 
SUMMARY OF THE PRESENT INVENTION 
[0017] The device is designed to allow selective collection 
of breath condensate contained within the alveolar volume 
of expired breath. The device consists of port into which a 
patient breathes, connected in fluid series to a chamber with 
a port to allow transmission and measurement of percentage 
absorption of a light beam in the exhaled sample. In a 
preferred embodiment, when the concentration of C02 
increases above a specified threshold, or increases at a 
specified rate, a rotary solenoid is actuated which is con-
nected to a valve. This action causes the valve to rotate 90°, 
causing the exhaled breath to be diverted into a condensing 
chamber. 
[0018] Other general features include a built-in refrigera-
tion system, a built-in analyzer, a flow transducer and 
microcontroller for measuring total volume of exhaled 
breath and signaling the user when a sufficient volume has 
been detected, and a housing in which the various compo-
nents may be carried, including some disposable compo-
nents and some reusable components. 
[0019] Broadly defined, the present invention according to 
one aspect is a method of diagnosing particular diseases 
based on expired breath from a mammalian subject, includ-
ing: providing a breath condensate collection device having 
condensing chamber, a fluid inlet and a fluid outlet; cooling 
the condensing chamber; receiving, at the fluid inlet, at least 
one exhaled breath from a mammalian subject; separating 
the exhaled breath into an expired airway phase volume and 
an alveolar phase volume; condensing portions of either the 
expired airway phase portion of the exhaled breath or the 
alveolar phase volume of the exhaled breath, but not both, in 
the condensing chamber to produce condensate on the inner 
surfaces of the condensing chamber; removing the conden-
sate from the condensing chamber; analyzing the condensate 
for markers indicative of respiratory disease; and rendering 
a diagnosis at least partly on the basis of whether the 
condensate being analyzed came, from the expired airway 
phase portion of the exhaled breath or the alveolar phase 
volume of the exhaled breath. 
[0020] In features of this aspect, the separating takes place 
between the fluid inlet and the condensing chamber; the 
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markers include biochemicals; the biochemicals include 
inorganic gases, volatile organic molecules, proteins, 
nucleic acids, lipids, lipid A, endotoxin and other impervi-
ous nonorganic exogenous materials; the markers include 
microbes; the microbes include viruses, fungi, mycoplasma, 
mycobacteria, bacteria, prions and protozoa; only the alveo-
lar phase volume of the exhaled breath reaches the condens-
ing chamber; alternatively, only the expired airway phase 
volume of the exhaled breath reaches the condensing cham-
ber; the receiving, separating and condensing steps are 
repeated in order to increase the amount of condensate 
produced in the condensing chamber; and the method further 
includes expressing the condensate from the condensing 
chamber using a piston assembly. 
[0021] Broadly defined, the present invention according to 
another aspect is a method of collecting breath condensate 
from a portion of exhaled breath from a mammalian subject 
by separating the expired airway phase of the breath from 
the alveolar phase, including: providing a cartridge assem-
bly and a condensing chamber, the cartridge assembly 
having a breathing port and at least two fluid outlets, at least 
one of which is in fluid communication with the condensing 
chamber; cooling the condensing chamber; receiving, at the 
breathing port in the cartridge assembly, at least one exhaled 
breath from a mammalian subject; monitoring, in the car-
tridge assembly, at least one characteristic of the exhaled 
breath, the characteristic generally capable of distinguishing 
the expired airway phase of the breath from the alveolar 
phase of the breath; based on the state of the monitored 
characteristic, diverting the flow of the exhaled breath 
through the cartridge assembly from one fluid outlet to the 
other fluid outlet; and upon receiving a diverted portion of 
the exhaled breath from the cartridge assembly, condensing 
portions of the exhaled breath to produce condensate on the 
inner surfaces of the condensing chamber. 
[0022] In features of this aspect, monitoring includes 
determining when the exhaled breath has transitioned from 
the expired airway phase to the alveolar phase, and diverting 
the flow of the exhaled breath based on the state of the 
monitored characteristic includes diverting the exhaled 
breath to the condensing chamber once it is determined that 
the alveolar phase of the exhaled breath has begun; cooling 
the condensing chamber includes cooling the condensing 
chamber to a temperature of less than 0° F.; the diverting 
step includes adjusting the state of a valve assembly to 
prevent the exhaled breath from passing into the condensing 
chamber until the alveolar phase of the exhaled breath has 
begun and to force the exhaled breath into the condensing 
chamber once the alveolar phase of the exhaled breath has 
begun; cooling the condensing chamber includes cooling the 
condensing chamber to a temperature of less than 0° C.; and 
the method further includes expressing the condensate from 
the condensing chamber using a piston assembly. 
[0023] In other features of this aspect, determining when 
the exhaled breath has transitioned from the expired airway 
phase to the alveolar phase includes determining when a 
predetermined level of a particular predetermined gas is 
reached; the particular predetermined gas is selected from 
the group consisting of C02 , 0 2 , N2 , CO and NO; the 
monitoring, diverting and condensing steps are repeated in 
order to increase the amount of condensate produced in the 
condensing chamber; the monitoring, diverting and con-
densing steps are repeated for a predetermined period of 
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time; the monitoring, diverting and condensing steps are 
repeated until a predetermined volume of gas has passed into 
the condensing chamber; the monitoring and diverting steps 
are carried out automatically; and monitoring includes deter-
mining when the exhaled breath has transitioned from the 
expired airway phase to the alveolar phase, and diverting the 
flow of the exhaled breath based on the state of the moni-
tored characteristic includes diverting the exhaled breath to 
the condensing chamber until it is determined that the 
alveolar phase of the exhaled breath has begun. 
[0024] Broadly defined, the present invention according to 
another aspect is breath condensate collection apparatus 
including: a cartridge assembly having a breathing port 
adapted to permit a mammalian subject to breathe in and out 
of the cartridge assembly, at least a first fluid outlet and a 
second fluid outlet, a monitoring system adapted to monitor 
at least one characteristic of a generally gaseous fluid 
passing through the cartridge assembly, the at least one 
characteristic generally capable of distinguishing the 
expired airway phase of an exhaled breath from the mam-
malian subject from the alveolar phase of the exhaled breath, 
and a valve assembly operable to divert the flow of fluid, 
received via the breathing port, to either the first fluid outlet 
or the second fluid outlet on the basis of the state of the 
monitored characteristic; and a condensing chamber having 
double'side walls, including an inner side wall and an outer 
side wall in spaced relationship to one another, and first and 
second opposing ends, the condensing chamber being in 
fluid communication with at least one fluid outlet of the 
cartridge assembly. 
[0025] In features of this aspect, the condensing chamber 
includes an outlet and a one-way valve adapted to prevent 
gas from being drawn into the condensing chamber during 
an inhalation by the mammalian subject while permitting 
exhaled breath to be exhausted therethrough during an 
exhalation by the mammalian subject; the condensing cham-
ber is cooled to a temperature of less than 0° F.; the 
condensing chamber is cooled to a temperature of less than 
0° C.; the apparatus further includes a plunger assembly 
having a piston and a handle, the piston being slidably 
disposed in the interior of the condensing chamber in snug 
contact with the inner side wall and the handle extending 
from the first end of the condensing chamber so as to permit 
the piston to be moved within the central chamber; and in 
addition to the first one-way valve, the cartridge assembly 
further includes an inhalation port and a second one-way 
valve adapted to permit breathing gas to be drawn into the 
cartridge assembly during an inhalation by the mammalian 
subject, and the cartridge assembly further includes a third 
one-way valve in at least one of the at least two fluid outlets 
adapted to prevent gas from being drawn into the cartridge 
assembly during an inhalation by the mammalian subject 
while permitting exhaled breath to be exhausted there-
through during an exhalation by the mammalian subject. 
[0026] In other features of this aspect, the actuator device 
operates the valve assembly to divert the flow of fluid, 
received via the breathing port, to the second fluid outlet 
instead of to the first fluid outlet when a predetermined level 
of a particular predetermined gas is reached; the predeter-
mined level is reached by the level of the predetermined gas 
rising to the predetermined level; the predetermined level is 
reached by the level of the predetermined gas dropping to 
the predetermined level; the particular predetermined gas is 
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selected from the group consisting of C02 , 0 2 , N2 , CO and 
NO; the breathing port, the at least two fluid outlets and the 
valve assembly define a cartridge, and the apparatus further 
includes a housing adapted to carry the cartridge, the moni-
toring system and the condensing chamber; and the cartridge 
is adapted to be removable from the housing for disposal 
after a single use, while the monitoring system is adapted for 
repeated reuse. 
[0027] In still further features of this aspect, the actuator 
device operates the valve assembly to divert the flow of 
fluid, received via the breathing port, to the fluid outlet 
connected to the condensing chamber when the predeter-
mined level of the particular. predetermined gas is reached; 
the actuator device operates the valve assembly to divert the 
flow of fluid, received via the breathing port, away from the 
fluid outlet connected to the condensing chamber when the 
predetermined level of the particular predetermined gas is 
reached; the valve assembly includes a valve adjustable 
between at least two positions, such that in the first valve 
assembly state the valve is in a first position diverting fluid 
received at the breathing port to the first fluid outlet and 
away from the second fluid outlet, and in the second valve 
assembly state the valve is in a second position diverting 
fluid received at the breathing port to the second fluid outlet 
and away from the first fluid outlet; the valve is a directional 
flap; the actuator device is a rotary solenoid; and the valve 
assembly includes at least two valves. 
[0028] Broadly defined, the present invention according to 
another aspect is an apparatus for separating the expired 
airway phase of breath exhaled by a mammalian subject 
from the alveolar phase of the exhaled breath, including: a 
fluid inlet; at least a first fluid outlet and a second fluid outlet; 
a valve assembly adjustable between at least two states: a 
first state wherein fluid received at the fluid inlet is diverted 
to the first fluid outlet, and a second state wherein fluid 
received at the fluid inlet is diverted to the second fluid 
outlet; and a control system that adjusts the state of the valve 
assembly, having a spectrometer arranged to monitor at least 
one characteristic of a generally gaseous fluid passing 
through the separation apparatus, the characteristic generally 
capable of distinguishing the expired airway phase of an 
exhaled breath from a mammalian subject from the alveolar 
phase of the exhaled breath, and an actuator device, coupled 
to the spectrometer and the valve assembly, that adjusts the 
state of the valve assembly on the basis of the state of the 
monitored characteristic. 
[0029] In features of this aspect, the spectrometer is 
arranged to measure the partial pressure of a particular 
predetermined gas in the gaseous fluid passing through the 
separation apparatus; the actuator device adjusts the state of 
the valve assembly from its first state to its second state 
when the partial pressure of the particular predetermined gas 
reaches a predetermined level; the partial pressure reaches 
the predetermined level by rising to the predetermined level; 
the partial pressure reaches the predetermined level by 
dropping to the predetermined level; the particular prede-
termined gas is selected from the group consisting of C02 , 
0 2 , N2 , CO and NO; the fluid inlet, the at least two fluid 
outlets and the valve assembly define a cartridge assembly, 
and the apparatus further includes a housing adapted to carry 
the cartridge assembly and the control system; and the 
cartridge assembly is adapted to be removable from the 
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housing for disposal after a single use, while the control 
system is adapted for repeated reuse. 
[0030] In other features of this aspect, the apparatus fur-
ther includes a chamber having an inlet connected in fluid 
communication with one of the at least two fluid outlets and 
adapted to collect at least a portion of the generally gaseous 
fluid passing through the separation apparatus; the chamber 
is a condensing chamber adapted to collect liquid condensed 
out of the generally gaseous fluid; the chamber is connected 
to the second fluid outlet, and the actuator device adjusts the 
valve assembly from the first state to the second state when 
the partial pressure reaches the predetermined level; the 
chamber is connected to the second fluid outlet, and the 
actuator device adjusts the valve assembly from the second 
state to the first state when the partial pressure reaches the 
predetermined level; the valve assembly includes a valve 
adjustable between at least two positions such that in the first 
valve assembly state the valve is in a first position diverting 
fluid received at the fluid inlet to the first fluid outlet and 
away from the second fluid outlet, and in the second valve 
assembly state the valve is in a second position diverting 
fluid received at the fluid inlet to the second fluid outlet and 
away from the first fluid outlet; the valve is a directional flap; 
the actuator device is a rotary solenoid; and the valve 
assembly includes at least two valves. 
[0031] Broadly defined, the present invention according to 
another aspect is a breath condensate collection apparatus 
including: a housing; a condensing chamber, carried by the 
housing, having an inlet that receives exhaled breaths from 
a mammalian subject and an outlet that permits a gaseous, 
non-condensed portion of the exhaled breaths to escape from 
the condensing chamber; and a built-in refrigeration system, 
carried by the housing, having a compressor, an expansion 
valve, an evaporator pipe arranged to cool the condensing 
chamber, and a condenser-pipe arranged to dissipate heat 
away from the condensing chamber. 
[0032] In features of this aspect, the housing includes a 
cavity correspondingly shaped and sized to carry the con-
densing chamber, and the evaporator pipe is disposed gen-
erally around the cavity; when the condensing chamber is 
carried in the cavity, the condensing chamber makes contact 
with a substantial portion of the evaporator pipe; the con-
densing chamber has walls constructed from a good heat 
conducting material; the walls of the condensing chamber 
are constructed from aluminum; the apparatus further 
includes a ventilation system that dissipates heat generated 
by the refrigeration system; the ventilation system includes 
one or more vents in the housing; the ventilation system 
includes one or more fans; and the apparatus further includes 
a temperature gauge arranged to provide an indication of the 
temperature of the condensing chamber. 
[0033] Broadly defined, the present invention according to 
another aspect is a portable breath condensate collection 
apparatus including: a housing having at least one compart-
ment adapted to receive and generally enclose a removable 
cartridge and a removable condensing chamber in fluid 
communication with one another; a removable, disposable 
cartridge, having at least one inlet, at least one outlet and a 
mouthpiece in fluid communication with at least one inlet, 
carried in the at least one compartment of the housing such 
that at least a portion of the mouthpiece is carried externally 
to the housing; and a removable condensing chamber, hav-
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ing an inlet and an outlet, carried in the at least one 
compartment of the housing such that the inlet is in fluid 
communication with at least one outlet of the cartridge and 
the outlet is open to the environment. 
[0034] In features of this aspect, the at least one compart-
ment includes a compartment having a first section and a 
second section, the cartridge is carried in the first compart-
ment section and the condensing chamber is carried in the 
second compartment section; alternatively, the at least one 
compartment includes at least a first compartment and a 
second compartment, the cartridge is carried in the first 
compartment and the condensing chamber is carried in the 
second compartment; the cartridge includes a valve assem-
bly for alternately permitting or preventing the flow of fluids 
through the cartridge and into the condensing chamber; the 
apparatus further includes a control system, carried by and 
generally enclosed in the housing, for the valve assembly; 
and the control system is adapted to remain in the housing 
for repeated reuse while the cartridge and the condensing 
chamber are removed. 
[0035] In other features of this aspect, the apparatus fur-
ther includes an analyzer, carried by and generally enclosed 
in the housing, adapted to provide information regarding the 
content of breath condensate received therein, and a conduit 
disposed in sealed fluid communication between the con-
densing chamber and the analyzer, adapted to guide breathe 
condensate from the condensing chamber to the analyzer; 
wherein the condensing chamber further includes a piston 
and a handle, the piston is slidably disposed in the interior 
of the condensing chamber in snug contact with the inside of 
the condensing chamber and the handle extends from the 
first end of the condensing chamber so as to permit the 
piston to be moved within the central chamber; and the 
piston is operable to force breath condensate collected in the 
condensing chamber to the conduit leading to the analyzer. 
[0036] Broadly defined, the present invention according to 
another aspect is a breath condensate collection apparatus 
including: a housing; a condensing chamber, carried by the 
housing; an inlet, carried by the housing, that receives 
exhaled breath from a mammalian subject; a conduit dis-
posed in sealed fluid communication between the inlet and 
the condensing chamber; a gas flow measurement device, 
disposed in the conduit, that measures the flow of gas 
through the conduit; and a control system, coupled to the gas 
flow measurement device, that determines when a predeter-
mined volume of gas has passed through the conduit. 
[0037] In features of this aspect, the conduit, the gas flow 
measurement device and the control system are carried by 
the housing; the apparatus further includes a signaling 
device that generates a user-identifiable indication that the 
predetermined volume of gas has passed through the con-
duit; the gas flow measurement device is a gas flow trans-
ducer and the control system includes a microcontroller that 
is electrically connected to the gas flow transducer; the 
signaling device includes a speaker that generates a user-
audible signal; the user-audible signal changes, as a mam-
malian subject breathes through the apparatus, to provide an 
indication of progress toward reaching the predetermined 
volume of gas; the signaling device includes at least one 
user-visible light; and the at least one user-visible light 
includes a plurality of user-visible lights that light sequen-
tially, as a mammalian subject breathes through the appa-
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ratus, to provide an indication of progress toward reaching 
the predetermined volume of gas. 
[0038] Broadly defined, the present invention according to 
another aspect is a breath condensate collection apparatus 
for separating the expired airway phase of breath exhaled by 
a mammalian subject from the alveolar phase of the exhaled 
breath, including: a housing; a cartridge assembly having a 
breathing port, at least two fluid outlets, a valve assembly 
adjustable between at least two states, including a first state 
wherein gas received at the breathing port is diverted to a 
first of the at least two fluid outlets, and a second state 
wherein gas received at the breathing port is diverted to a 
second of the at least two fluid outlets, a monitoring system 
arranged to monitor at least one characteristic of gas passing 
through the separation apparatus, the characteristic generally 
capable of distinguishing the expired airway phase of an 
exhaled breath from a mammalian subject from the alveolar 
phase of the exhaled breath, and an actuator device, coupled 
to the monitoring system and the valve assembly, that 
adjusts the valve assembly state on the basis of the state of 
the monitored characteristic; a condensing chamber, having 
an inlet and an outlet, carried by the housing such that the 
inlet is in fluid communication with at least one outlet of the 
cartridge assembly and the outlet is open to the environment; 
and a built-in refrigeration system, carried by the housing. 
[0039] In features of this aspect, the housing includes at 
least one compartment adapted to receive and generally 
enclose the cartridge assembly and the condensing chamber 
in fluid communication with one another; the condensing 
chamber is adapted to be removed from the housing after use 
and replaced by a previously-unused condensing chamber; 
the cartridge assembly is adapted to be removed from the 
housing after use and replaced by an unused cartridge 
assembly; the condensing chamber has double side walls 
and first and second opposing ends, and the double side 
walls include an inner side wall and an outer side wall in 
spaced relationship to one another; the built-in refrigeration 
system includes a compressor, an expansion valve, an 
evaporator pipe arranged to cool the condensing chamber, 
and a condenser pipe arranged to dissipate heat away from 
the condensing chamber; and the apparatus further includes 
a conduit disposed in sealed fluid communication between 
the valve assembly and the condensing chamber, a gas flow 
measurement device, disposed in the conduit, that measures 
the flow of gas through the conduit, and a control system, 
coupled to the gas flow measurement device, that determines 
when a predetermined volume of gas has passed through the 
conduit. 
BRIEF DESCRIPTION OF THE DRAWINGS 
[0040] Further features, embodiments, and advantages of 
the present invention will become apparent from the fol-
lowing detailed description with reference to the drawings, 
wherein: 
[0041] FIG. 1 is a side view of a device for collection of 
exhaled alveolar breath condensate in accordance with a 
preferred embodiment of the present invention; 
[0042] FIG. 2 is a front view of the device of FIG. 1; 
[0043] FIG. 3 is a top view of the housing of FIG. 1 with 
the cartridge lid removed to show the cartridge assembly; 
[0044] FIG. 4 is a top view of the housing of FIG. 1 with 
the cartridge assembly and the syringe removed; 
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[0045] FIG. 5 is a side cross-sectional view of the device 
of FIG. 2, taken along line 5-5; 
[0046] FIG. 6 is a schematic view of the cartridge assem-
bly of FIG. 3; 
[0047] FIG. 7 is an enlarged perspective view of the 
cartridge of FIG. 1; 
[0048] FIG. 8 is a right side view of the cartridge of FIG. 
7; 
[0049] FIG. 9 is a top view of the cartridge of FIG. 7; 
[0050] FIG. 10 is a rear view of the cartridge of FIG. 7; 
[0051] FIG. 11 is a side view of the directional flap of 
FIG. 7; 
[0052] FIG. 12 is a side perspective view of the direc-
tional flap of FIG. 7; 
[0053] FIG. 13 is a partially-schematic side cross-sec-
tional view of the cartridge of FIG. 10, taken along line 
13-13, showing the directional flap in a closed position; 
[0054] FIG. 14 is a partially-schematic side cross-sec-
tional view of the cartridge of FIG. 10, taken along line 
13-13, showing the directional flap in an open position; 
[0055] FIG. 15 is a left side view of the cartridge of FIG. 
7 showing the attachment of a spring to the directional flap; 
[0056] FIG. 16 is a rear view of the cartridge assembly of 
FIG. 3, shown removed from the housing; 
[0057] FIG. 17 is an enlarged perspective view of the 
rotary solenoid of FIG. 16; 
[0058] FIG. 18 is a side view of a first exemplary syringe 
for use in the device of FIG. 1; 
[0059] FIG. 19 is a front view of the syringe of FIG. 18; 
[0060] FIG. 20 is a side cross-sectional view of the 
syringe of FIG. 19, taken along line 20-20; 
[0061] FIG. 21 is a side cross-sectional view of a device 
for collection of exhaled alveolar breath condensate in 
accordance with a second preferred embodiment of the 
present invention; 
[0062] FIG. 22 is a side cross-sectional view of a device 
for collection of exhaled alveolar breath condensate in 
accordance with a third preferred embodiment of the present 
invention; 
[0063] FIG. 23 is a side cross-sectional view of the device 
of FIG. 22 showing the plunger assembly in a fully inserted 
position; and 
[0064] FIG. 24 is a schematic view of an auxiliary control 
system for use with the device of FIGS. 1, 21 and 22. 
DETAILED DESCRIPTION OF IBE 
PREFERRED EMBODIMENTS 
[0065] Referring now to the drawings, in which like 
numerals represent like components throughout the several 
views, the preferred embodiments of the present invention 
are next described. The following description of the pre-
ferred embodiment(s) is merely exemplary in nature and is 
in no way intended to limit the invention, its application, or 
uses. 
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[0066] FIG. 1 is a side view of a device 10 for collection 
of exhaled alveolar breath condensate in accordance with a 
preferred embodiment of the present invention. The device 
10 includes a housing 12, a disposable mouthpiece 14, a 
handle 16, an intake cartridge assembly 20 and a syringe 80. 
The size and shape of the housing 12 and the handle 16 are 
designed to permit the device 10 to be readily held by a 
patient, but the device 10 may also be mounted on the side 
of a hospital bed or gurney, attached to a rolling mobile 
stand, or the like, using suitable mounting hardware (not 
shown). 
[0067] FIG. 2 is a front view of the device 10 of FIG. 1. 
The housing 12 is generally cylindrical and is designed to 
support the intake cartridge assembly 20 and the syringe 80 
therein. The housing 12 includes a cartridge lid 13 secured 
to the remainder of the housing 12 by a hinge 11. The 
cartridge lid 13 may thus be opened to facilitate access to the 
cartridge assembly 20 disposed inside the housing 12. 
[0068] FIG. 3 is a top view of the housing 12 of FIG. 1 
with the cartridge lid 13 removed to show the cartridge 
assembly 20, FIG. 4 is a top view of the housing 12 of FIG. 
1 with the cartridge assembly 20 and the syringe 80 
removed, and FIG. 5 is a side cross-sectional view of the 
device 10 of FIG. 2, taken along line 5-5. As shown therein, 
the housing 12 may include a variety of compartments, 
recesses, pockets or the like for receiving the various com-
ponents of the device 10. In particular, one end of the 
housing 12 may be devoted to the components of the 
cartridge assembly 20, while the other end houses the 
syringe 80. The housing 10 includes a cartridge compart-
ment, a two spectrometer pockets, an actuator pocket, and 
other pockets and recesses for various parts and functions 
described below. In addition, the housing 12 includes exter-
nal openings through at each end as well as two openings in 
its bottom and an opening penetrating the cartridge lid 13. 
The purpose of each of these openings will become apparent 
hereinbelow. 
[0069] FIG. 6 is a schematic view of the cartridge assem-
bly 20 of FIG. 3. The cartridge assembly 20 includes a 
disposable cartridge 22 and a control system 60. The control 
system 60 is used to control a directional flap 36 in the 
cartridge 22, which regulates the path of exhaled breath 
through the cartridge 22. The operation of the control system 
60 and the cartridge 22 will be more fully described here-
inbelow. 
[0070] FIGS. 7-10 are perspective, right side, top and rear 
views of the cartridge 22 of FIGS. 5 and 6. The cartridge 22 
may be formed from polyethylene, polycarbonate, polyvi-
nyl, plastic, glass or the like and includes a breathing port 24, 
an inhalation port 26, an absorption chamber 28, a collection 
port 30, an exhaust vent 32, a pair of spectrometer windows 
34 and a valve assembly that may include the directional flap 
36, a spring 50 and a pin or boss 52 protruding from an 
exterior surface of the cartridge 22. The breathing port 24 is 
fluidly connected between the absorption chamber 28 and 
the mouthpiece 14 to permit a user to breathe in and out 
through the cartridge 22. The inhalation port 26 includes a 
one-way valve 27 that permits ambient air to be drawn 
through the cartridge 22 during the user's inhalation cycle. 
The collection port 30 is in fluid communication with the 
syringe 80 and includes a one-way valve 31 to prevent gases 
in the syringe 80 from returning to the cartridge 22. The 
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exhaust vent 32 permits unwanted exhaled breath to be 
vented to the environment and includes a one-way valve 33 
to prevent air from entering the cartridge 22 therethrough. It 
should be noted that although FIGS. 7 and 10, and some of 
the other illustrations, show the exhaust vent 32 as being 
round, it may be preferable for the exhaust vent 32 to be 
rectangular or some other shape. The emitter and sensor 
units 64, 66 of a spectrometer or other monitoring system 62 
may be stationed adjacent the spectrometer windows 34, as 
described below, in order to measure the content of gas 
contained in the absorption chamber 28 of the cartridge 22. 
[0071] FIGS. 11 & 12 are side and perspective views, 
respectively, of the directional flap 36 of FIG. 7. The 
directional flap 36 includes a central shaft 37, arranged 
around an axial pin 44, from which a deflector plate 38 is 
supported by a pair of arms 39, 41. As illustrated in FIG. 8, 
a pair of tabs 40, 42 extend laterally from the ends of a flange 
43, supported by the central shaft 37, for purposes made 
clear hereinbelow. The directional flap 36 may be adjusted 
to force the exhaled breath in the interior of the cartridge 22 
to be exhausted either through the collection port 30 or the 
exhaust vent 32. As perhaps best shown in FIGS. 8 and 9, 
the flap 36 is supported in the interior if the cartridge 22 by 
the arms 39, 41, which extend through slots 45 in the sides 
of the cartridge 22. 
[0072] FIGS. 13 and 14 are partially-schematic side 
cross-sectional views of the cartridge 22 of FIG. 10, taken 
along line 13-13, showing the directional flap 36 in a closed 
position and an open position, respectively. In the closed 
position shown in FIG. 13, the deflector plate 38 blocks the 
air path to the collection port 30 that forms the portal 
between the cartridge 22 and the syringe 80. This forces all 
expelled breath to be exhausted through the exhaust vent 32. 
On the other hand, in the open position shown in FIG. 14, 
the deflector plate 38 covers the exhaust vent 32, forcing all 
expelled breath through the collection port 30 and into the 
syringe 80. Preferably, gaskets 46, 48 or other sealing 
devices and methods may be used to seal the deflector plate 
38 and any other necessary surfaces of the directional flap 36 
to the various internal structures of the cartridge 22 in order 
to ensure that gases of the wrong type are not passed through 
the wrong opening. 
[0073] FIG. 15 is a left side view of the cartridge 22 of 
FIG. 7 showing the attachment of the spring 50 to the 
directional flap 36. The spring 50 or an equivalent device is 
preferably provided in order to bias the directional flap 36 in 
a normally-closed position. One purpose of this is to prevent 
gases and fluids collected in the syringe 80 from escaping 
back through the cartridge 22. In one embodiment, the 
spring 50 is a simple coil spring that is interconnected 
between one of the tabs 42 on the directional flap 36 and the 
boss 52 on the exterior surface of the cartridge 22, as perhaps 
best shown in FIGS. 9 and 10. Other biasing devices and 
methods will be apparent to one of ordinary skill in the art. 
[0074] Moreover, it will be apparent that the valve assem-
bly may take on any number of different constructions. For 
example, the directional flap 36 and the biasing device may 
be internalized within the cartridge 22 in order to provide 
better sealing, improve operation, or the like. Further, the 
valve assembly may include two flap-type valves operating 
in conjunction with each other instead of the single flap 36 
disclosed and described herein, or the directional flap 36 
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may be replaced with a valve mechanism of any suitable 
alternative type, including but not limited to one rotary 
valve, a sliding door, a slip barrel, a plunger, or the like, with 
corresponding changes to the cartridge, biasing device, and 
the like being apparent to those of skill in the art. 
[0075] Returning to FIG. 6, the control system 60 includes 
a monitoring system 62, a control unit 67 and an actuator 
device 70. The control unit 67 may include an amplifier/ 
differentiator 68 and a monitoring system controller 69. A 
variety of monitoring systems may be employed using 
different physical phenomena as triggers for the directional 
flap. One monitoring system 62 suitable for use in the 
preferred embodiments of the present invention is a spec-
trometer, which may be of any conventional type, including 
infrared (IR), laser, and the like, and includes a radiation 
source, or emitter unit 64, disposed on one side of the 
absorption chamber 28 and a sensor unit 66 disposed on the 
opposite side, adjacent the spectrometer windows 34. FIG. 
16 is a rear view of the cartridge assembly 20 of FIG. 3, 
shown removed from the housing 12. In operation, radiation 
from the emitter unit 64 passes through the spectrometer 
window on one side of the cartridge 22, through the absorp-
tion chamber 28 and through the absorption window 34 to 
the sensor unit 66, where the received radiation is analyzed. 
[0076] IR spectrometers may use chopped IR light emis-
sion, where the emission is chopped at a frequency appro-
priate to distinguish absorbance of the gas of interest, such 
as co2, from background absorbance. Alternatively, laser 
diode spectrometry can be used for detection of more than 
one gas for the purpose of actuating the directional flap and 
for the purpose of determining the presence of various 
pathophysiological processes that are specific to certain 
disease states. Lasers using AlGaAs, AlGainP or a Vertical 
Cavity diodes operating in the near infrared or visible light 
spectrum at room temperature and ambient pressure in the 
1-100 mW power range will be sufficient. The physical 
length between the emission and detection probe will be 
approximately 1-3 cm, but the apparent pathlength may be 
increased by light reflection using dielectrim mirrors to 
increase sensitivity. Detection wavelengths will be 1390 nm 
for C02 and 760 nm for 0 2 , but other gases may be detected 
by the laser to assist in diagnosis of specific diseases, 
including lung ischemia, by the detection of the relative 
amounts of nitric oxide (NO) at 1800 nm and carbon 
monoxide (CO) at 1570 nm. It is anticipated that further 
research will reveal significance of laser-based quantifica-
tion of other inorganic gases and volatile organic compounds 
to serve as adjuncts to the chemical analyses of the breath 
condensate in arriving at a final diagnosis of certain disease 
processes. 
[0077] Spectrometers are available from a variety of 
manufacturers, and the selection and implementation of one 
suitable for use with the present invention would be apparent 
to one of ordinary skill in the art. As is well known, the 
sensor unit 66 measures the percent transmission of the 
radiation to allow measurement of the partial pressure of 
certain gases in the absorption chamber 28. Measured gases 
may include carbon dioxide, oxygen, nitrogen, nitrogen 
oxides, carbon monoxide, aliphatic and aromatic hydrocar-
bons, isoprostenoid derivatives, or amino acids dissolved in 
exhaled aerosolized droplets. 
[0078] One type of actuator device 70 suitable for use in 
the preferred embodiments of the present invention is a 
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rotary solenoid. The rotary solenoid 70 utilizes a clutch 
mechanism to adjust or move the directional flap 36 back 
and forth between its open and closed positions. FIG. 17 is 
an enlarged perspective view of the rotary solenoid 70 of 
FIG. 16. As illustrated therein, an actuator shaft 74 extends 
from the solenoid body 72. A slot 76 in the end of the 
actuator shaft 74 may be firmly coupled to one of the tabs 40 
on the directional flap 36 in order to provide rotational 
movement to the tab 40 and likewise rotating the directional 
flap 36 between its open and closed positions. If necessary, 
the directional flap tab 40 and the actuator shaft 74 of the 
rotary solenoid 70 may be disposed coaxially with the pin 44 
of the directional flap in order to minimize wear on the 
components. Rotary solenoids 70 are available from a vari-
ety of manufacturers, and the selection and implementation 
of one suitable for use with the present invention would be 
apparent to one of ordinary skill in the art. It should also be 
apparent that other actuating devices and methods may be 
employed without departing from the scope of the present 
invention, including pulley mechanisms, magnetic actuation 
of a metallic valve, and the like, triggered from expired 
volume measured from a flow transducer rather than from 
light-absorption technique. 
[0079] FIGS. 18 and 19 are side and front views, respec-
tively, of a first exemplary syringe 80 for use in the device 
80 of FIG. 1. As illustrated therein, the syringe 80 includes 
an insulated condensing chamber 82 having a plunger 
assembly 84, an inlet 86 and an exhaust port 88. The 
condensing chamber 82 may be constructed of any suitable 
material, including, but not limited to, glass, plastic, poly-
ethylene, polycarbonate, or polyvinyl or other synthetic 
polymer. 
[0080] FIG. 20 is a side cross-sectional view of the 
syringe 80 of FIG. 18, taken along line 20-20. As shown 
therein, the insulative effect of the condensing chamber 82 
may be provided by any of a variety of materials either 
formed directly into the walls (not illustrated) of the con-
densing chamber or sandwiched between an inner wall 90 
and an outer wall 92. Arranged peripherally between the 
inner and outer walls 90, 92 is a layer of a material 94 
suitable for creating an endothermic reaction, such as 
NH4 N03 , that has been vacuum-packed and sealed. The 
condensing chamber 82 is preferably provided with a needle 
port 96 or some other means for permitting the sealed 
material 94 to be hydrated or otherwise injected with a 
readily available catalyst in order to trigger an endothermic 
reaction when the syringe 80 is ready to be used. If NH4 N03 
is to be used, then the NH4N03 may be hydrated with water 
in a 1:4 molar ratio. Such a material is preferred because a 
user may trigger the reaction by injecting the NH4 N03 
material with a preset volume of tap water or saline via the 
needle port 96, similar to the way a nurse would "flush" an 
IV line. However, other materials may likewise be used to 
create a suitable endothermic reaction. 
[0081] The inner surfaces of the condensing chamber 82 
define a central cylinder in which is fitted the plunger 
assembly 84. The plunger assembly 84 includes a piston 98, 
a rubber gasket 100, a handle 102 extending from one end 
of the condensing chamber 82, and a clip assembly 104 
disposed at the handle end of the condensing chamber 82. 
The inlet 86 is preferably disposed at the opposite end of the 
condensing chamber 82 from the plunger assembly 84 and 
may be arranged in the form of a nipple. The exhaust port 88 
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is preferably disposed at the same end of the condensing 
chamber 82 as the handle 102 and is equipped with a 
one-way valve 106 to permit gases passing through the 
condensing chamber 82 to be exhausted therethrough while 
preventing ambient gases from entering the condensing 
chamber 82. 
[0082] Although not shown herein, a second exemplary 
syringe suitable for use (with minor modifications) in the 
device 10 of FIG. 1 is a double-walled syringe of a type 
somewhat similar to one disclosed in the commonly-as-
signed U.S. Provisional Patent Application No. 60/434,916, 
filed Dec. 20, 2002. The construction of this syringe is 
similar to that of the first, except that the space between the 
inner and outer walls of the condensing chamber is filled 
with water, polyethylene glycol ("PEG"), or another suitable 
coolant material and the outer wall is then sealed to the inner 
wall to prevent leakage. A syringe of this type may be cooled 
by placing it in a standard freezer prior to use in order to 
lower the temperature of the syringe to less than 0° F., and 
preferably to less than 0° C. Details of this type of syringe 
are provided in the aforementioned provisional patent appli-
cation. 
[0083] In operation, the housing lid 13 is opened and the 
cartridge assembly 20 is inserted into the housing 12 such 
that the various components are snapped into place in their 
respective compartments in the housing 12. Next, a syringe 
80 of one of the types described above is retrieved from 
storage and inserted into the open end of the housing 12, 
nipple-shaped inlet 86 first, and pushed inward until the inlet 
86 is coupled to the collection port 30 of the cartridge 22. 
[0084] Depending on the syringe type, the syringe 80 may 
have been stored in a refrigeration device, such as a con-
ventional household freezer, that is capable of lowering the 
temperature to less than 0° F., and preferably less than 0° C., 
in order to freeze the jacket of coolant material 94 contained 
between the inner and outer walls 90, 92 of the condensing 
chamber 82. Alternatively, syringes of the endothermic 
reaction type may merely be stored at an ambient tempera-
ture and then cooled to the desired temperature by triggering 
an endothermic reaction therein when ready for use. If the 
mouthpiece 14 is stored separately from the rest of the 
device 10, then the mouthpiece 14 may be assembled to the 
cartridge assembly 20. In some applications, such as when 
the device 10 is to be attached to a bed or to a rolling stand, 
it may be useful to connect the mouthpiece 14 to a longer 
tube (not shown) in sealed fluid communication with the 
breathing port 24 of the cartridge 22. 
[0085] Once the device 10 is assembled, the patient posi-
tions the mouthpiece 14 in sealed relationship to his mouth 
area and inhales and exhales through the mouthpiece 14. 
When the patient inhales, ambient air enters through the 
inhalation port 26 via the one-way valve 27. The exhaled 
breath is guided into the absorption chamber 28 via the 
breathing port 24. Under the control of the monitoring 
system controller 69, the spectrometer 62 measures the 
partial pressure of certain gases in the absorption chamber 
28 and delivers an analog current to the amplifier/differen-
tiator 68. For example, the magnitude of the analog signal 
may be proportional to the amount of C02 present in the 
absorption chamber 28. 
[0086] At the beginning of an expiration by the patient, the 
patient's breath is dilute in carbon dioxide and rich in 
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oxygen. In one preferred embodiment, the rotary solenoid 70 
and the amplifier/differentiator 68 are calibrated such that 
the directional flap 36 remains in its resting state, wherein 
the flap 36 is held in its closed position by the spring 50, and 
the airway deadspace is shunted out the exhaust vent 32 to 
the environment. As the patient's alveoli begin to empty 
during expiration, the partial pressure of C02 increases and 
the partial pressure of oxygen decreases. The resulting signal 
generated by the amplifier/differentiator 68 eventually acti-
vates the solenoid 70, causing the directional flap 36 to open. 
At this point, the alveolar gas and associated water content 
are directed selectively to the syringe 80. 
[0087] To maximize the efficiency of collection of breath 
condensate, the deadspace volume of the cartridge 22 should 
preferably be minimized to less than 20 mL. It will also be 
preferable for patients to exhale deeply through the device 
10 in order to enhance the amount of condensation in the 
alveolar phase. Thermodynamic and kinetic modeling has 
suggested that forced exhalation will enhance the transfer of 
alveolar water into vapor and droplet phase. Thus the device 
10 is preferably designed to impart a small resistance to 
exhaled flow. The outlet diameter and length of the collec-
tion port 30, connected to the condensing chamber 82, will 
be calibrated to provide a small amount of resistance to 
exhalation, which the patient should be able to detect, but 
which is not enough to cause exhalation to be excessively 
laborious. 
[0088] As portions of the expired breath pass into the 
syringe 80, the moisture in the breath begins to condense on 
the inner surfaces of the condensing chamber 82. Because of 
the depressed temperature of the condensing chamber 82, 
condensate begins to collect and may immediately freeze on 
the inner surfaces thereof. Once the patient's breath has 
warmed the condensing chamber 82 sufficiently, the con-
densate will melt and may be expressed from the condensing 
chamber 82. The construction of the condensing chamber 82 
is preferably calibrated to provide a sufficient quantity of 
condensate (approximately 250 microliters) after a prede-
termined number of breaths. When sufficient condensate has 
been collected, the syringe 80 may be removed from the 
housing 12 and the plunger assembly 84 depressed to force 
the collected condensate from the nipple 86 as described 
previously. Finally, once the condensate has been collected 
and withdrawn, the mouthpiece 14, the cartridge 22 (but 
preferably not the control system 60, which is designed to 
remain uncontaminated and would be relatively expensive to 
replace after each use) and the syringe 80 may be disposed 
of according to conventional waste disposition procedures, 
and the collected condensate may be taken to a suitable 
analyzer for analysis. 
[0089] Because of the relatively small quantities of liquid 
condensate that may typically be collected using devices 10 
of the present invention, it may be useful to include spe-
cialized features in the piston 98 and other components in 
order to maximize the amount of condensate that may be 
collected. For example, although not absolutely necessary, 
the piston 98 shown in the various illustrations includes a tip 
or protrusion 99 of dimensions and shape suitable for fitting 
snugly into the nipple-shaped inlet 86 when the plunger 
assembly 84 is fully depressed. This helps to ensure that as 
much condensate as possible is forced out of the inlet 86. In 
addition, however, the protrusion 99 may, for example, 
include grooves, tunnels, or the like for guiding condensate 
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from the condensing chamber 82 to the inlet 86 and out. 
Specialized pistons 98 such as these are more fully described 
in the aforementioned U.S. Provisional Patent Application 
No. 60/434,916. 
[0090] The analysis of the collected condensate may be 
carried out using any conventional analysis technique or 
system. The analysis may focus on identifying and quanti-
fying the presence of a variety of markers of various 
respiratory diseases. The markers may include microbes 
such as viruses, fungi, mycoplasma, mycobacteria, bacteria, 
prions and protozoa, and biochemicals such as inorganic 
gases, volatile organic molecules, proteins, nucleic acids, 
lipids, lipid A, endotoxin and other impervious nonorganic 
exogenous materials such as inhaled particulate including 
asbestos, silicates, coal dust and the like. These markers and 
the analysis techniques and systems are well known to those 
of ordinary skill in the art. Once the analysis is complete, 
however, a more accurate diagnosis may be made by taking 
into account the exhalation cycle phase or phases in which 
the markers were found. 
[0091] FIG. 21 is a side cross-sectional view of a device 
110 for collection of exhaled alveolar breath condensate in 
accordance with a second preferred embodiment of the 
present invention. In this alternative embodiment preferred 
for its completely self-contained nature, the device 110 
includes a refrigeration system 120 built into its housing 
112. The refrigeration system 120 is generally of conven-
tional design and includes a compressor 122, an expansion 
valve (not shown), a distribution system 126 and an exhaust 
system 140. However, it should be apparent that other types 
of cooling systems may likewise be utilized without depart-
ing from the scope of the present invention. For example, 
instead of a conventional refrigeration system 120, the 
alternative device 110 may utilize a cooling jacket com-
prised of a layer of a liquid having a very low freezing point, 
such as PEG, in a bag made of rubber or the like, or may use 
an electric cooler making use of the thermoelectric effect, or 
other cooling methodologies. 
[0092] The device 110 may utilize an alternative syringe 
180 having a single-walled condensing chamber 182 and a 
plunger assembly and other features as described herein. The 
distribution system 126 is a piping or tubing structure having 
a evaporator (cold) pipe or coil 128 and a condenser (hot) 
coil 130. The evaporator coil 128 surrounds the recess into 
which the condensing chamber 182 is inserted. Although not 
shown herein, the evaporator coil 128 may even make direct 
contact with the wall of the condensing chamber 182. 
Preferably, the walls of the condensing chamber 182 are 
formed of aluminum or another good heat conducting mate-
rial, thus permitting the refrigeration system 120 to rapidly 
cool the condensing chamber 182, thus facilitating breath 
condensate collection within seconds of inserting the syringe 
180 therein. 
[0093] The condenser coil 130 may be cooled using con-
vection cooling via the exhaust system 140, which may 
include fans 142 and vents 144 such as those shown in the 
side and end, respectively, of the housing 112 in FIG. 21. 
The exhausted heat should preferably be directed away from 
the patient. The compressor 122 may operate using standard 
110 volt electrical power or using power supplied by a 
suitable battery pack. A temperature gauge (not shown) may 
be provided to indicate when the temperature of the con-
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<lensing chamber 182 has been lowered sufficiently to allow 
breath condensation to occur with adequate efficiency, which 
may be important if the device 110 has not been used for an 
extended period of time. 
[0094] FIG. 22 is a side cross-sectional view of a device 
210 for collection of exhaled alveolar breath condensate in 
accordance with a third preferred embodiment of the present 
invention. In this alternative embodiment preferred for its 
still greater functionality and convenience, the device 210 
includes a built-in breath condensate analyzer 220. The 
built-in analyzer feature may be combined with the built-in 
refrigeration system 120 described above, or may be utilized 
separately. In order to deliver the collected condensate to the 
analyzer 220, a syringe 280 having a special condensing 
chamber 282 may be utilized. The condensing chamber 282 
differs from previously-described condensing chambers 82, 
182 in that it includes a small side port 283 extending 
radially from the entry end of the condensing chamber 282. 
This permits collected condensate to be expressed directly 
into the analyzer 220. In addition, it should be noted that the 
plunger assembly 84 must include a tip or protrusion 99 of 
a type described previously (or a similar structure) in order 
to completely plug the nipple-shaped inlet 86 of the con-
densing chamber 282, thereby preventing condensate from 
passing back into the cartridge 22 when the plunger assem-
bly 84 is depressed. 
[0095] In use, a syringe 280 is first inserted into the 
housing 212 of the device 210. A groove or channel may be 
provided in the recess of the housing 212 in order to guide 
the side port 283 into fluid communication with an inlet 221 
for the analyzer 220. If the device 210 is equipped with a 
built-in refrigeration system 120 as described previously, 
then the condensing chamber 282 may be cooled once it is 
in place in the housing 112; otherwise, the condensing 
chamber 282 should be cooled ahead of time. Condensate is 
then collected in a similar manner to that described herein-
above. When sufficient condensate has been collected, the 
plunger assembly 84 may be depressed until the plunger 
handle 102 snaps into place. FIG. 23 is a side cross-sectional 
view of the device of FIG. 22 showing the plunger assembly 
84 in a fully inserted position. This forces the analyte out of 
the side port 283 and into the analyzer 220, which may 
include an analysis matrix, such as an immunoassay screen, 
or permits it to be aspirated by vacuum into an analysis 
chamber contained within the housing 212 of the device 210. 
[0096] FIG. 24 is a schematic view of an auxiliary control 
system 54 for use with the devices 10, 110, 210 of FIGS. 1, 
21 and 22. The auxiliary control system 54 includes a flow 
transducer 55, a microcontroller or other computer device or 
electronic logic module 56, and one or more signaling 
devices 57, 58. The flow transducer 55 may be installed 
anywhere along the flow path extending from the directional 
flap 36 in the cartridge 22 to the exhaust port 88 of the 
respective syringe 80, 180. 280 but is preferably installed at 
the collection port 30 of the cartridge 22. The microcontrol-
ler 56 is interconnected between the flow transducer 55 and 
the signaling devices 57, 58. 
[0097] In operation, the flow transducer 55 measures the 
exhaled alveolar volume passing through the collection port 
30 of the cartridge 22 and generates a corresponding analog 
signal that is monitored by the microcontroller 56. The 
exhaled alveolar volume that is required in order to produce 
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the volume of condensate needed for accurate chemical 
analyses can be preprogrammed, based upon experimental 
analysis, into the microcontroller 56. When the microcon-
troller 56 determines that that volume has been reached, it 
transmits a suitable electronic signal to the signaling devices 
57, 58, which may include a speaker, one or more LED's or 
other visual signal devices, or the like. Thus, when the 
speaker 57 sounds or the LED's 58 light, the operator of the 
respective device 10, 110, 210 is notified that the breath 
collection process has been completed. Alternatively, the 
microcontroller 56 may utilize a more complex signaling 
pattern, wherein the audible signal emitted by the speaker 57 
rises in pitch or in intensity as the process progresses, or a 
series of LED's 58 are sequentially lit as the process 
progresses. This approach allows the patient and operator to 
know how much more breathing is required to complete 
condensation collection, which may be particularly advan-
tageous for breath collection from children. 
[0098] It should be apparent that the devices 10, 110, 210 
of various embodiments of the present invention may also be 
used to capture expired breath from the expired airway 
phase, rather than the alveolar phase, merely by reversing 
the triggering point for the solenoid 70. This may be 
accomplished by calibrating the rotary solenoid 70 and the 
amplifier/differentiator 68 such that the directional flap 36 is 
initially held in its active state, wherein the flap 36 is held 
in its open position by the solenoid 70. Alternatively, the 
spring 50 or other biasing means may be adjusted to bias the 
directional flap 36 in its open position, and the control 
system 60 may be adjusted such that when the solenoid 70 
is activated, the flap 36 is closed. 
[0099] The operation of this variation is as follows. As 
described previously, at the beginning of an expiration by 
the patient, the patient's breath is dilute in carbon dioxide 
and rich in oxygen. Thus, when the flap 36 is open, the 
airway deadspace and associated water content are directed 
selectively to the syringe 80. As the patient's alveoli begin 
to empty during expiration, the partial pressure of C02 
increases and the partial pressure of oxygen decreases. The 
resulting signal generated by the amplifier/differentiator 68 
eventually deactivates the solenoid 70, causing the direc-
tional flap 36 to close. At this point, the alveolar gas is 
shunted out the exhaust vent 32 to the environment. The 
threshold concentration value for C02 is preferably set at 
approximately 4 torr, so that once the concentration of C02 
exceeds that value, the actuator device 70 closes the flap 36, 
thus preventing further exhaled breath from passing into the 
syringe 80. 
[0100] Thus, this alternative arrangement may be used to 
provide specific separation of the expired airway phase from 
the alveolar phase. More specifically, this would allow 
selective spectrophotometric measurement of expired con-
centrations of inorganic gases and volatile organic com-
pounds, as well as collection of expired condensate derived 
only from the airway phase of exhalation. Then, the con-
densing chamber 82 could be replaced and the triggering 
mechanism could be reset to alveolar collection mode, and 
the process repeated. Because the condensate collected 
during alveolar collection mode would be from the same 
subject as that collected during the expired airway mode, the 
cartridge 22 would not necessarily need to be replaced when 
changing modes; however, the cartridge 22 may likewise be 
replaced, if desired, in order to avoid contaminating the 
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condensate collected in one mode with any residual con-
densate or remaining fluids still present in the cartridge 22 
after operation in the first mode. 
[0101] The advantage of this differential sample collection 
would be the distinction of pathological processes affecting 
the lining of the bronchial tree versus processes primarily 
affecting the alveoli. The ability to distinguish lower airway 
disease (e.g., on the basis of differential measurement of 
inflammatory markers) from diseases affecting the conduct-
ing tract can have important ramifications on treatment. 
[0102] Based on the foregoing information, it is readily 
understood by those persons skilled in the art that the present 
invention is susceptible of broad utility and application. 
Many embodiments and adaptations of the present invention 
other than those specifically described herein, as well as 
many variations, modifications, and equivalent arrange-
ments, will be apparent from or reasonably suggested by the 
present invention and the foregoing descriptions thereof, 
without departing from the substance or scope of the present 
invention. Accordingly, while the present invention has been 
described herein in detail in relation to its preferred embodi-
ment, it is to be understood that this disclosure is only 
illustrative and exemplary of the present invention and is 
made merely for the purpose of providing a full and enabling 
disclosure of the invention. The foregoing disclosure is not 
intended to be construed to limit the present invention or 
otherwise exclude any such other embodiments, adaptations, 
variations, modifications or equivalent arrangements; the 
present invention being limited only by the claims appended 
hereto and the equivalents thereof. Although specific terms 
are employed herein, they are used in a generic and descrip-
tive sense only and not for the purpose of limitation. 
What is claimed is: 
1. A method of diagnosing particular diseases based on 
expired breath from a mammalian subject, comprising: 
providing a breath condensate collection device having 
condensing chamber, a fluid inlet and a fluid outlet; 
cooling the condensing chamber; 
receiving, at the fluid inlet, at least one exhaled breath 
from a mammalian subject; 
separating the exhaled breath into an expired airway 
phase volume and an alveolar phase volume; 
condensing portions of either the expired airway phase 
portion of the exhaled breath or the alveolar phase 
volume of the exhaled breath, but not both, in the 
condensing chamber to produce condensate on the 
inner surfaces of the condensing chamber; 
removing the condensate from the condensing chamber; 
analyzing the condensate for markers indicative of respi-
ratory disease; and 
rendering a diagnosis at least partly on the basis of 
whether the condensate being analyzed came from the 
expired airway phase portion of the exhaled breath or 
the alveolar phase volume of the exhaled breath. 
2. The method of claim 1, wherein the separating takes 
place between the fluid inlet and the condensing chamber. 
3. The method of claim 2, wherein the markers include 
biochemicals. 
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4. The method of claim 3, wherein the biochemicals 
include inorganic gases, volatile organic molecules, pro-
teins, nucleic acids, lipids, lipid A, endotoxin and other 
impervious nonorganic exogenous materials. 
5. The method of claim 2, wherein the markers include 
microbes. 
6. The method of claim 5, wherein the microbes include 
viruses, fungi, mycoplasma, mycobacteria, bacteria, prions 
and protozoa. 
7. The method of claim 2, wherein only the alveolar phase 
volume of the exhaled breath reaches the condensing cham-
ber. 
8. The method of claim 2, wherein only the expired 
airway phase volume of the exhaled breath reaches the 
condensing chamber. 
9. The method of claim 2, wherein the receiving, sepa-
rating and condensing steps are repeated in order to increase 
the amount of condensate produced in the condensing cham-
ber. 
10. The method of claim 9, further comprising: 
expressing the condensate from the condensing chamber 
using a piston assembly. 
11. A method of collecting breath condensate from a 
portion of exhaled breath from a mammalian subject by 
separating the expired airway phase of the breath from the 
alveolar phase, the method comprising: 
providing a cartridge assembly and a condensing cham-
ber, the cartridge assembly having a breathing port and 
at least two fluid outlets, wherein at least one fluid 
outlet is in fluid communication with the condensing 
chamber; 
cooling the condensing chamber; 
receiving, at the breathing port in the cartridge assembly, 
at least one exhaled breath from a mammalian subject; 
monitoring, in the cartridge assembly, at least one char-
acteristic of the exhaled breath, the characteristic gen-
erally capable of distinguishing the expired airway 
phase of the breath from the alveolar phase of the 
breath; 
based on the state of the monitored characteristic, divert-
ing the flow of the exhaled breath through the cartridge 
assembly from one fluid outlet to the other fluid outlet; 
and 
upon receiving a diverted portion of the exhaled breath 
from the cartridge assembly, condensing portions of the 
exhaled breath to produce condensate on the inner 
surfaces of the condensing chamber. 
12. The method of claim 11, wherein monitoring includes 
determining when the exhaled breath has transitioned from 
the expired airway phase to the alveolar phase, and wherein 
diverting the flow of the exhaled breath based on the state of 
the monitored characteristic includes diverting the exhaled 
breath to the condensing chamber once it is determined that 
the alveolar phase of the exhaled breath has begun. 
13. The method of claim 12, wherein cooling the con-
densing chamber includes cooling the condensing chamber 
to a temperature of less than 0° F. 
14. The method of claim 13, wherein the diverting step 
includes adjusting the state of a valve assembly to prevent 
the exhaled breath from passing into the condensing cham-
ber until the alveolar phase of the exhaled breath has begun 
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and to force the exhaled breath into the condensing chamber 
once the alveolar phase of the exhaled breath has begun. 
15. The method of claim 13, wherein cooling the con-
densing chamber includes cooling the condensing chamber 
to a temperature of less than 0° C. 
16. The method of claim 13, further comprising: 
expressing the condensate from the condensing chamber 
using a piston assembly. 
17. The method of claim 13, wherein determining when 
the exhaled breath has transitioned from the expired airway 
phase to the alveolar phase includes determining when a 
predetermined level of a particular predetermined gas is 
reached. 
18. The method of claim 17, wherein the particular 
predetermined gas is selected from the group consisting of 
C02 , 0 2 , N2 , CO and NO. 
19. The method of claim 13, wherein the monitoring, 
diverting and condensing steps are repeated in order to 
increase the amount of condensate produced in the condens-
ing chamber. 
20. The method of claim 19, wherein the monitoring, 
diverting and condensing steps are repeated for a predeter-
mined period of time. 
21. The method of claim 19, wherein the monitoring, 
diverting and condensing steps are repeated until a prede-
termined volume of gas has passed into the condensing 
chamber. 
22. The method of claim 12, wherein the monitoring and 
diverting steps are carried out automatically. 
23. The method of claim 11, wherein monitoring includes 
determining when the exhaled breath has transitioned from 
the expired airway phase to the alveolar phase, and wherein 
diverting the flow of the exhaled breath based on the state of 
the monitored characteristic includes diverting the exhaled 
breath to the condensing chamber until it is determined that 
the alveolar phase of the exhaled breath has begun. 
24. A breath condensate collection apparatus comprising: 
(a) a cartridge assembly including: 
a breathing port adapted to permit a mammalian subject 
to breathe in and out of the cartridge assembly, 
at least a first fluid outlet and a second fluid outlet, 
a monitoring system adapted to monitor at least one 
characteristic of a generally gaseous fluid passing 
through the cartridge assembly, the at least one 
characteristic generally capable of distinguishing the 
expired airway phase of an exhaled breath from the 
mammalian subject from the alveolar phase of the 
exhaled breath, and 
a valve assembly operable to divert the flow of fluid, 
received via the breathing port, to either the first fluid 
outlet or the second fluid outlet on the basis of the 
state of the monitored characteristic; and 
(b) a condensing chamber having double side walls and 
first and second opposing ends, wherein the double side 
walls include an inner side wall and an outer side wall 
in spaced relationship to one another, wherein the 
condensing chamber is in fluid communication with at 
least one fluid outlet of the cartridge assembly. 
25. The breath condensate collection apparatus of claim 
24, wherein the condensing chamber includes an outlet and 
a one-way valve adapted to prevent gas from being drawn 
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into the condensing chamber during an inhalation by the 
mammalian subject while permitting exhaled breath to be 
exhausted therethrough during an exhalation by the mam-
malian subject. 
26. The breath condensate collection apparatus of claim 
25, wherein the condensing chamber is cooled to a tempera-
ture of less than 0° F. 
27. The breath condensate collection apparatus of claim 
26, wherein the condensing chamber is cooled to a tempera-
ture of less than 0° C. 
28. The breath condensate collection apparatus of claim 
26, further comprising a plunger assembly having a piston 
and a handle, wherein the piston is slidably disposed in the 
interior of the condensing chamber in snug contact with the 
inner side wall and wherein the handle extends from the first 
end of the condensing chamber so as to permit the piston to 
be moved within the central chamber. 
29. The breath condensate collection apparatus of claim 
28, wherein the one-way valve is a first one-way valve, 
wherein the cartridge assembly further includes an inhala-
tion port and a second one-way valve adapted to permit 
breathing gas to be drawn into the cartridge assembly during 
an inhalation by the mammalian subject, and the cartridge 
assembly further includes a third one-way valve in at least 
one of the at least two fluid outlets adapted to prevent gas 
from being drawn into the cartridge assembly during an 
inhalation by the mammalian subject while permitting 
exhaled breath to be exhausted therethrough during an 
exhalation by the mammalian subject. 
30. The apparatus of claim 25, wherein the actuator device 
operates the valve assembly to divert the flow of fluid, 
received via the breathing port, to the second fluid outlet 
instead of to the first fluid outlet when a predetermined level 
of a particular predetermined gas is reached. 
31. The apparatus of claim 30, wherein the predetermined 
level is reached by the level of the predetermined gas rising 
to the predetermined level. 
32. The apparatus of claim 30, wherein the predetermined 
level is reached by the level of the predetermined gas 
dropping to the predetermined level. 
33. The apparatus of claim 30, wherein the particular 
predetermined gas is selected from the group consisting of 
C02 , 0 2 , N2 , CO and NO. 
34. The apparatus of claim 30, wherein the breathing port, 
the at least two fluid outlets and the valve assembly define 
a cartridge, and wherein the apparatus further comprises a 
housing adapted to carry the cartridge, the monitoring sys-
tem and the condensing chamber. 
35. The apparatus of claim 34, wherein the cartridge is 
adapted to be removable from the housing for disposal after 
a single use, while the monitoring system is adapted for 
repeated reuse. 
36. The apparatus of claim 30, wherein the actuator device 
operates, the valve assembly to divert the flow of fluid, 
received via the breathing port, to the fluid outlet connected 
to the condensing chamber when the predetermined level of 
the particular predetermined gas is reached. 
37. The apparatus of claim 30, wherein the actuator device 
operates the valve assembly to divert the flow of fluid, 
received via the breathing port, away from the fluid outlet 
connected to the condensing chamber when the predeter-
mined level of the particular predetermined gas is reached. 
38. The apparatus of claim 25, wherein the valve assem-
bly includes a valve adjustable between at least two posi-
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tions, wherein in the first valve assembly state the valve is 
in a first position diverting fluid received at the breathing 
port to the first fluid outlet and away from the second fluid 
outlet, and wherein in the second valve assembly state the 
valve is in a second position diverting fluid received at the 
breathing port to the second fluid outlet and away from the 
first fluid outlet. 
39. The apparatus of claim 38, wherein the valve is a 
directional flap. 
40. The apparatus of claim 39, wherein the actuator device 
is a rotary solenoid. 
41. The apparatus of claim 25, wherein the valve assem-
bly includes at least two valves. 
42. An apparatus for separating the expired airway phase 
of breath exhaled by a mammalian subject from the alveolar 
phase of the exhaled breath, the apparatus comprising: 
(a) a fluid inlet; 
(b) at least a first fluid outlet and a second fluid outlet; 
(c) a valve assembly adjustable between at least two 
states, the at least two states including a first state 
wherein fluid received at the fluid inlet is diverted to the 
first fluid outlet, and a second state wherein fluid 
received at the fluid inlet is diverted to the second fluid 
outlet; and 
( d) a control system that adjusts the state of the valve 
assembly, the control system including: 
a spectrometer arranged to monitor at least one char-
acteristic of a generally gaseous fluid passing 
through the separation apparatus, the characteristic 
generally capable of distinguishing the expired air-
way phase of an exhaled breath from a mammalian 
subject from the alveolar phase of the exhaled 
breath, and 
an actuator device, coupled to the spectrometer and the 
valve assembly, that adjusts the state of the valve 
assembly on the basis of the state of the monitored 
characteristic. 
43. The apparatus of claim 42, wherein the spectrometer 
is arranged to measure the partial pressure of a particular 
predetermined gas in the gaseous fluid passing through the 
separation apparatus. 
44. The apparatus of claim 43, wherein the actuator device 
adjusts the state of the valve assembly from its first state to 
its second state when the partial pressure of the particular 
predetermined gas reaches a predetermined level. 
45. The apparatus of claim 44, wherein the partial pres-
sure reaches the predetermined level by rising to the prede-
termined level. 
46. The apparatus of claim 44, wherein the partial pres-
sure reaches the predetermined level by dropping to the 
predetermined level. 
47. The apparatus of claim 44, wherein the particular 
predetermined gas is selected from the group consisting of 
C02 , 0 2 , N2 , CO and NO. 
48. The apparatus of claim 44, wherein the fluid inlet, the 
at least two fluid outlets and the valve assembly define a 
cartridge assembly, and wherein the apparatus further com-
prises a housing adapted to carry the cartridge assembly and 
the control system. 
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49. The apparatus of claim 48, wherein the cartridge 
assembly is adapted to be removable from the housing for 
disposal after a single use, while the control system is 
adapted for repeated reuse. 
50. The apparatus of claim 44, further comprising a 
chamber having an inlet connected in fluid communication 
with one of the at least two fluid outlets and adapted to 
collect at least a portion of the generally gaseous fluid 
passing through the separation apparatus. 
51. The apparatus of claim 50, wherein the chamber is a 
condensing chamber adapted to collect liquid condensed out 
of the generally gaseous fluid. 
52. The apparatus of claim 50, wherein the chamber is 
connected to the second fluid outlet, and wherein the actua-
tor device adjusts the valve assembly from the first state to 
the second state when the partial pressure reaches the 
predetermined level. 
53. The apparatus of claim 50, wherein the chamber is 
connected to the second fluid outlet, and wherein the actua-
tor device adjusts the valve assembly from the second state 
to the first state when the partial pressure reaches the 
predetermined level. 
54. The apparatus of claim 43, wherein the valve assem-
bly includes a valve adjustable between at least two posi-
tions, wherein in the first valve assembly state the valve is 
in a first position diverting fluid received at the fluid inlet to 
the first fluid outlet and away from the second fluid outlet, 
and wherein in the second valve assembly state the valve is 
in a second position diverting fluid received at the fluid inlet 
to the second fluid outlet and away from the first fluid outlet. 
55. The apparatus of claim 54, wherein the valve is a 
directional flap. 
56. The apparatus of claim 55, wherein the actuator device 
is a rotary solenoid. 
57. The apparatus of claim 43, wherein the valve assem-
bly includes at least two valves. 
58. A breath condensate collection apparatus comprising: 
(a) a housing; 
(b) a condensing chamber, carried by the housing, having 
an inlet that receives exhaled breaths from a mamma-
lian subject and an outlet that permits a gaseous, 
non-condensed portion of the exhaled breaths to escape 
from the condensing chamber; and 
(c) a built-in refrigeration system, carried by the housing, 
including: 
a compressor, 
an expansion valve, 
an evaporator pipe arranged to cool the condensing 
chamber, and 
a condenser pipe arranged to dissipate heat away from 
the condensing chamber. 
59. The breath condensate collection apparatus of claim 
58, wherein the housing includes a cavity correspondingly 
shaped and sized to carry the condensing chamber, and 
wherein the evaporator pipe is disposed generally around the 
cavity. 
60. The breath condensate collection apparatus of claim 
59, wherein when the condensing chamber is carried in the 
cavity, the condensing chamber makes contact with a sub-
stantial portion of the evaporator pipe. 
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61. The breath condensate collection apparatus of claim 
59, wherein the condensing chamber has walls constructed 
from a good heat conducting material. 
62. The breath condensate collection apparatus of claim 
61, wherein the walls of the condensing chamber are con-
structed from aluminum. 
63. The breath condensate collection apparatus of claim 
59, further comprising a ventilation system that dissipates 
heat generated by the refrigeration system. 
64. The breath condensate collection apparatus of claim 
63, wherein the ventilation system includes one or more 
vents in the housing. 
65. The breath condensate collection apparatus of claim 
63, wherein the ventilation system includes one or more 
fans. 
66. The breath condensate collection apparatus of claim 
59, further comprising a temperature gauge arranged to 
provide an indication of the temperature of the condensing 
chamber. 
67. A portable breath condensate collection apparatus 
comprising: 
a housing having at least one compartment adapted to 
receive and generally enclose a removable cartridge 
and a removable condensing chamber in fluid commu-
nication with one another; 
a removable, disposable cartridge, having at least one 
inlet, at least one outlet and a mouthpiece in fluid 
communication with at least one inlet, carried in the at 
least one compartment of the housing such that at least 
a portion of the mouthpiece is carried externally to the 
housing; and 
a removable condensing chamber, having an inlet and an 
outlet, carried in the at least one compartment of the 
housing such that the inlet is in fluid communication 
with at least one outlet of the cartridge and the outlet is 
open to the environment. 
68. The portable breath condensate collection apparatus 
of claim 67, wherein the at least one compartment includes 
a compartment having a first section and a second section, 
wherein the cartridge is carried in the first compartment 
section and the condensing chamber is carried in the second 
compartment section. 
69. The portable breath condensate collection apparatus 
of claim 67, wherein the at least one compartment includes 
at least a first compartment and a second compartment, 
wherein the cartridge is carried in the first compartment and 
the condensing chamber is carried in the second compart-
ment. 
70. The portable breath condensate collection apparatus 
of claim 67, wherein the cartridge includes a valve assembly 
for alternately permitting or preventing the flow of fluids 
through the cartridge and into the condensing chamber. 
71. The portable breath condensate collection apparatus 
of claim 70, further comprising a control system, carried by 
and generally enclosed in the housing, for the valve assem-
bly. 
72. The portable breath condensate collection apparatus 
of claim 71, wherein the control system is adapted to remain 
in the housing for repeated reuse while the cartridge and the 
condensing chamber are removed. 
73. The portable breath condensate collection apparatus 
of claim 67, further comprising an analyzer, carried by and 
generally enclosed in the housing, adapted to provide infor-
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mation regarding the content of breath condensate received 
therein, and a conduit disposed in sealed fluid communica-
tion between the condensing chamber and the analyzer, 
adapted to guide breathe condensate from the condensing 
chamber to the analyzer. 
74. The portable breath condensate collection apparatus 
of claim 73, wherein the condensing chamber further 
includes a piston and a handle, wherein the piston is slidably 
disposed in the interior of the condensing chamber in snug 
contact with the inside of the condensing chamber and 
wherein the handle extends from the first end of the con-
densing chamber so as to permit the piston to be moved 
within the central chamber. 
75. The portable breath condensate collection apparatus 
of claim 74, wherein the piston is operable to force breath 
condensate collected in the condensing chamber to the 
conduit leading to the analyzer. 
76. A breath condensate collection apparatus, comprising: 
a housing; 
a condensing chamber, carried by the housing; 
an inlet, carried by the housing, that receives exhaled 
breath from a mammalian subject; 
a conduit disposed in sealed fluid communication between 
the inlet and the condensing chamber; 
a gas flow measurement device, disposed in the conduit, 
that measures the flow of gas through the conduit; and 
a control system, coupled to the gas flow measurement 
device, that determines when a predetermined volume 
of gas has passed through the conduit. 
77. The breath condensate collection apparatus of claim 
76, wherein the conduit, the gas flow measurement device 
and the control system are carried by the housing. 
78. The breath condensate collection apparatus of claim 
77, further comprising a signaling device that generates a 
user-identifiable indication that the predetermined volume of 
gas has passed through the conduit. 
79. The breath condensate collection apparatus of claim 
78, wherein the gas flow measurement device is a gas flow 
transducer and the control system includes a microcontroller 
that is electrically connected to the gas flow transducer. 
80. The breath condensate collection apparatus of claim 
78, wherein the signaling device includes a speaker that 
generates a user-audible signal. 
81. The breath condensate collection apparatus of claim 
80, wherein the user-audible signal changes, as a mamma-
lian subject breathes through the apparatus, to provide an 
indication of progress toward reaching the predetermined 
volume of gas. 
82. The breath condensate collection apparatus of claim 
78, wherein the signaling device includes at least one 
user-visible light. 
83. The breath condensate collection apparatus of claim 
82, wherein the at least one user-visible light includes a 
plurality of user-visible lights that light sequentially, as a 
mammalian subject breathes through the apparatus, to pro-
vide an indication of progress toward reaching the prede-
termined volume of gas. 
84. A breath condensate collection apparatus for separat-
ing the expired airway phase of breath exhaled by a mam-
malian subject from the alveolar phase of the exhaled breath, 
the apparatus comprising: 
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(a) a housing; 
(b) a cartridge assembly including: 
a breathing port, 
at least two fluid outlets, 
a valve assembly adjustable between at least two states, 
the at least two states including a first state wherein 
gas received at the breathing port is diverted to a first 
of the at least two fluid outlets, and a second state 
wherein gas received at the breathing port is diverted 
to a second of the at least two fluid outlets, 
a monitoring system arranged to monitor at least one 
characteristic of gas passing through the separation 
apparatus, the characteristic generally capable of 
distinguishing the expired airway phase of an 
exhaled breath from a mammalian subject from the 
alveolar phase of the exhaled breath, and 
an actuator device, coupled to the monitoring system 
and the valve assembly, that adjusts the valve assem-
bly state on the basis of the state of the monitored 
characteristic; 
(c) a condensing chamber, having an inlet and an outlet, 
carried by the housing such that the inlet is in fluid 
communication with at least one outlet of the cartridge 
assembly and the outlet is open to the environment; and 
(d) a built-in refrigeration system, carried by the housing. 
85. The breath condensate collection apparatus of claim 
84, wherein the housing includes at least one compartment 
adapted to receive and generally enclose the cartridge 
assembly and the condensing chamber in fluid communica-
tion with one another. 
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86. The breath condensate collection apparatus of claim 
84, wherein the condensing chamber is adapted to be 
removed from the housing after use and replaced by a 
previously-unused condensing chamber. 
87. The breath condensate collection apparatus of claim 
84, wherein the cartridge assembly is adapted to be removed 
from the housing after use and replaced by an unused 
cartridge assembly. 
88. The breath condensate collection apparatus of claim 
84, wherein the condensing chamber has double side walls 
and first and second opposing ends, and wherein the double 
side walls include an inner side wall and an outer side wall 
in spaced relationship to one another. 
89. The breath condensate collection apparatus of claim 
84, wherein the built-in refrigeration system includes a 
compressor, an expansion valve, an evaporator pipe 
arranged to cool the condensing chamber, and a condenser 
pipe arranged to dissipate heat away from the condensing 
chamber. 
90. The breath condensate collection apparatus of claim 
84, further comprising: 
a conduit disposed in sealed fluid communication between 
the valve assembly and the condensing chamber; 
a gas flow measurement device, disposed in the conduit, 
that measures the flow of gas through the conduit; and 
a control system, coupled to the gas flow measurement 
device, that determines when a predetermined volume 
of gas has passed through the conduit. 
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